Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
Pashtoon Murtaza Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 127-134
Open Access | Times Cited: 272
Technological advancements in cancer diagnostics: Improvements and limitations
Akhil Pulumati, Anika Pulumati, Bilikere S. Dwarakanath, et al.
Cancer Reports (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 148
Practical recommendations for using ctDNA in clinical decision making
Stacey A. Cohen, Minetta C. Liu, Alexey Aleshin
Nature (2023) Vol. 619, Iss. 7969, pp. 259-268
Closed Access | Times Cited: 80
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care
Phillip G. Febbo, Mina Alsaraf Allo, Emma B. Alme, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 24
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers
Brandon M. Huffman, Vasily N. Aushev, Griffin Budde, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 41
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 37
Novel biomarkers for early detection of gastric cancer
Tasuku Matsuoka, Masakazu Yashiro
World Journal of Gastroenterology (2023) Vol. 29, Iss. 17, pp. 2515-2533
Open Access | Times Cited: 35
Regulatory implications of ctDNA in immuno-oncology for solid tumors
Paz J. Vellanki, Soma Ghosh, Anand Pathak, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005344-e005344
Open Access | Times Cited: 26
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung cancer
Aaron C. Tan, Gillianne Lai, Stephanie P.L. Saw, et al.
Cancer (2024) Vol. 130, Iss. 10, pp. 1758-1765
Open Access | Times Cited: 12
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies
Fernando O. Recio, Carly Bess Scalise, Paul Loar, et al.
Gynecologic Oncology (2024) Vol. 182, pp. 63-69
Open Access | Times Cited: 9
Minimal residue disease detection in early-stage breast cancer: a review
Yuan Zhang, Xiao‐Ying Yuan
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Strategies for improving detection of circulating tumor DNA using next generation sequencing
R. Tébar-Martínez, Jorge Martín-Arana, Francisco Gimeno-Valiente, et al.
Cancer Treatment Reviews (2023) Vol. 119, pp. 102595-102595
Open Access | Times Cited: 21
Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck
Natasha Honoré, Cédric van Marcke, Rachel Galot, et al.
Annals of Oncology (2023) Vol. 34, Iss. 12, pp. 1175-1186
Open Access | Times Cited: 20
Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future Challenges
Jordi Remón, Stephanie P.L. Saw, Francesco Cortiula, et al.
Journal of Thoracic Oncology (2023) Vol. 19, Iss. 2, pp. 199-215
Open Access | Times Cited: 17
Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer
Fabinshy Thangarajah, Jana Bußhoff, J Salamon, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 12597-12604
Open Access | Times Cited: 16
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay
Josette Northcott, Gábor Bartha, Jason Harris, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 200-218
Open Access | Times Cited: 7
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring
Alessandro Mannucci, Ajay Goel
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Measurable residual disease (MRD)-testing in haematological and solid cancers
Junren Chen, Robert Peter Gale, Yu Hu, et al.
Leukemia (2024) Vol. 38, Iss. 6, pp. 1202-1212
Open Access | Times Cited: 6
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
Gregory P. Botta, Maen Abdelrahim, Ronald Drengler, et al.
The Oncologist (2024) Vol. 29, Iss. 10, pp. 859-869
Open Access | Times Cited: 6
Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)
Huijuan Chen, Qiming Zhou
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 13
Enhancing Medical Diagnostics: Integrating AI for precise Brain Tumour Detection
Arohee Sinha, Tarun Kumar
Procedia Computer Science (2024) Vol. 235, pp. 456-467
Open Access | Times Cited: 5
Noninvasive Blood-Based Cancer Detection in Veterinary Medicine
Andi Flory, Heather Wilson‐Robles
Veterinary Clinics of North America Small Animal Practice (2024) Vol. 54, Iss. 3, pp. 541-558
Closed Access | Times Cited: 4
Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case report
James B. Yu, Trenton A Avriett, Christopher M Ray, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 1, pp. 485-490
Open Access | Times Cited: 4
Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities
Muttiah Barathan, Sook Luan Ng, Yogeswaran Lokanathan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 654-654
Open Access | Times Cited: 4
Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer
Isaac García-Murillas, Rosalind J. Cutts, Giselle Walsh-Crestani, et al.
Breast Cancer Research and Treatment (2024) Vol. 209, Iss. 3, pp. 493-502
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top